TrialPloS one2019

Safety of intravitreal ziv-aflibercept in choroido-retinal vascular diseases: A randomised double-blind intervention study.

Imoro Zeba Braimah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.